Remove Clinical Research Remove Pharma Companies Remove Research
article thumbnail

Why Do Pharma Companies Outsource to CROs?

Vial

To address these challenges, many companies outsource their clinical trials to contract research organizations (CROs) with established protocols, global reach, and therapeutic area expertise1. The demand for clinical trial outsourcing services is on the rise. over the forecast period (2022-2030).

article thumbnail

Women in STEM with Kristina Torfgard

Drug Target Review

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Survey Sheds Light on Current Trends & Opportunities in Site and Patient Recruitment

PPD

Their services help engage a suitable participant pool, facilitate clinical trial participation, ensure that selected sites have the resources to support clinical trial activities and more. Yet, respondents from companies across the spectrum hold similar views on how site and patient recruitment vendors can help solve the issue.

article thumbnail

How AI in pharma can live up to the hype 

Drug Discovery World

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. AI algorithms are able to quickly analyse and spot patterns in vast swathes of data.

article thumbnail

What is the largest CRO in the US?

Vial

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). ’s services include supporting life sciences research, analytical solutions, and diagnostics or developing and manufacturing therapeutic interventions. from 2024 to reach US$129.8 billion by 2029.

article thumbnail

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

H1 Blog

The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.”

FDA 59
article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture.

Drugs 189